« News

Cerbios’ HPAI manufacturing facility P5 meets control performance within SafeBridge’s® Category 4

Last summer, Cerbios-Pharma SA (from now on “Cerbios”) commissioned SafeBridge Europe, Ltd. (from now on “SafeBridge”) to carry out a surrogate containment performance assessment of three isolators located in P5 manufacturing unit at Cerbios site located in Lugano, Switzerland.

Cerbios_News_2010-8_-_Cerbios_HPAI_Manufacturing_unit_confirmed_Class_4.pdf